Clinical trial
Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD)
NCT00001206 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00001206 |
|---|---|
| Title | Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD) |
| Official title | Biological Markers in Childhood Psychiatric Disorders |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Attention Deficit and Disruptive Behavior Disorder, Attention Deficit Disorder With Hyperactivity |
| Enrollment | 347 |
| Start date | Jun 5, 1985 |
| Completion | May 15, 2017 |
| First posted | Nov 4, 1999 |
| Last update posted | Dec 16, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: